FDA.reportPublic FDA data

pasireotide 30 MG Injection [Signifor]

RxCUI
2049732
RxNorm name
pasireotide 30 MG Injection [Signifor]
Display name
pasireotide 30 MG Injection [Signifor]
Full name
pasireotide 30 MG Injection [Signifor]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:11

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Signifor LARPASIREOTIDERecordati Rare Diseases, Inc.a0aad470-3f38-af97-e053-2995a90a383a2024-07-16Warnings, Adverse reactionsExact identifier
rxcui: 2049732

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
a0aad470-3f38-af97-e053-2995a90a383aSignifor LAR 30 MG Injection [PSN] · pasireotide 30 MG Injection [Signifor] [SBD] · Signifor LAR (as pasireotide pamoate) 30 MG Injection [SY]317These highlights do not include all the information needed to use SIGNIFOR LAR safely and effectively. See full prescribing information for SIGNIFOR LAR. SIGNIFOR ® LAR (pasireotide) for injectable suspension, for intramuscular use Initial U.S. Approval: 201220240716